Charité - Universitätsmedizin Berlin

Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial (2024) Beck J, Fung C, Strbian D, Bütikofer L, Z'Graggen WJ, Lang MF, Beyeler S, et al. Journal article A prognostic neural epigenetic signature in high-grade glioma (2024) Drexler R, Khatri R, Sauvigny T, Mohme M, Maire CL, Ryba A, Zghaibeh Y, et al. Journal article Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024 (2024) Thill M, Janni W, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer J, Budach W, et al. Journal article, Review article Position statement on genuine physiotherapy research at German university hospitals Positionspapier zur genuinen physiotherapeutischen Forschung an den deutschen Universitätskliniken (2024) Klotz SG, Bökel A, Friderichs-Nedohibchenko M, Stickdorn I, Vogel B, Doods B, Feldmann F, et al. Journal article Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets (2024) Sandler Topelius N, Shokraneh F, Bahman M, Lahtinen J, Hassinen N, Airaksinen S, Verma S, et al. Journal article Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges (2024) Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, et al. Journal article Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation - A Retrospective Multicenter Outcome Analysis (2024) Assfalg V, Miller G, Stocker F, Hüser N, Hartmann D, Heemann U, Tieken I, et al. Journal article Monitoring spinal muscular atrophy with three-dimensional optoacoustic imaging (2024) Nedoschill E, Wagner AL, Danko V, Bühler A, Raming R, Jüngert JM, Neurath M, et al. Journal article Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors (2024) Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, Dücker P, et al. Journal article Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) (2024) Meyer-Wilmes P, Huober J, Untch M, Blohmer JU, Janni W, Denkert C, Klare P, et al. Journal article